Susquehanna International Group, LLP Ab Cellera Biologics Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$2.39 - $3.49 $123,563 - $180,433	-51,700 Reduced 81.42%	11,800 $30,000
Q2 2024 Aug 15, 2024	SELL	$2.73 - $4.73 $92,001 - $159,401	-33,700 Reduced 34.67%	63,500 $187,000
Q1 2024 May 07, 2024	SELL	$4.29 - $5.97 $515,229 - $716,997	-120,100 Reduced 55.27%	97,200 $440,000
Q4 2023 Feb 14, 2024	BUY	$3.91 - $5.93 $299,897 - $454,831	76,700 Added 54.55%	217,300 $1.24 Million
Q3 2023 Nov 14, 2023	SELL	$4.6 - $7.95 $587,420 - $1.02 Million	-127,700 Reduced 47.6%	140,600 $646,000
Q2 2023 Aug 11, 2023	SELL	$5.66 - $7.59 $1.02 Million - $1.37 Million	-180,000 Reduced 40.15%	268,300 $1.73 Million
Q1 2023 May 16, 2023	SELL	$7.31 - $11.18 $801,907 - $1.23 Million	-109,700 Reduced 19.66%	448,300 $3.38 Million
Q4 2022 Feb 14, 2023	SELL	$9.48 - $14.52 $19.9 Million - $30.4 Million	-2,096,900 Reduced 78.98%	558,000 $5.65 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $4.62 Million - $6.87 Million	502,000 Added 23.32%	2,654,900 $26.3 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $11.6 Million - $21.7 Million	2,035,400 Added 1732.26%	2,152,900 $22.9 Million
Q1 2022 May 16, 2022	BUY	$7.46 - $14.14 $381,206 - $722,554	51,100 Added 76.96%	117,500 $1.15 Million
Q4 2021 Feb 14, 2022	SELL	$12.99 - $17.73 $3.4 Million - $4.63 Million	-261,400 Reduced 79.74%	66,400 $950,000
Q3 2021 Nov 15, 2021	BUY	$14.85 - $21.34 $2.7 Million - $3.89 Million	182,100 Added 124.98%	327,800 $6.57 Million
Q2 2021 Aug 11, 2021	BUY	$20.19 - $34.17 $2.94 Million - $4.98 Million	145,700 New	145,700 $3.21 Million

Others Institutions Holding ABCL

# of Institutions

153

Shares Held

109M

Call Options Held

153K

Put Options Held

194K

Baker Bros. Advisors LP New York, NY

27.5M
Shares

$76 Million
0.76% of portfolio
Baillie Gifford & CO

12.9M
Shares

$35.6 Million
0.03% of portfolio
Voya Investment Management LLC Atlanta, GA

10.6M
Shares

$29.3 Million
0.03% of portfolio
Prosight Management, LP Dallas, TX

9.08M
Shares

$25.1 Million
6.31% of portfolio
Ubs Asset Management Americas Inc Chicago, IL

4.59M
Shares

$12.7 Million
0.0% of portfolio

View Full List

About AbCellera Biologics Inc.

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

More about ABCL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account